- Security Type
- Common Stock
- Min Investment
- Offering Date
- November 12, 2021
- Expected Close Date
- February 09, 2022
- Amount Raised
- Security Price
Key Deal Facts
XRHealth unlocked a distribution channel and revenue cycle for VR/AR technology, and is demonstrating strong revenue growth: XRHealth has generated over $1 million in revenue, and treated over 2,000 patients in Q1-Q3 of 2021and is showing 60% growth in revenue QoQ. With $20M raised to date, from crowdfunding, Angel investors, AARP and VCs, Including $4M in grants, with this new funding round, we believe we'll be able to continue to maintain this growth trajectory.
Unique Technology in a Large Market: The fast-growing Telehealth Market is predicted to reach a value of $70.19 billion by 2026. Combining XRHealth VR/AR Medical technology and generating valuable objective data points, allows telehealth clinicians to tailor individualized treatment plans for each patient and modify over the course of therapy. Our VR/AR telehealth technology is protected by 21 patents submitted by XRHealth, out of which 3 have been approved, 14 published and 4 pending.
Patient Satisfaction and Clinical Outcomes We have strong patient satisfaction, evidenced by XRHealth NPS (Net Promoter Score) of 74 (vs healthcare market average of 38) with 72% of patients agreeing we made a positive difference in their symptoms in under two weeks.
Common stock is a security that represents ownership in a corporation.
No reports have been submittedBecome a Reporter